IDEXX Laboratories, Inc. logo
IDEXX Laboratories, Inc. (IDXX)
Compare

IDEXX Laboratories, Inc. (IDXX) Free Cash Flow Yield: 2.31%

Is IDEXX Laboratories, Inc.’s free cash flow yield high or low?

IDEXX Laboratories, Inc.'s free cash flow yield of 2.31% is 40% above its 5-year average of 1.65%, near the high end of its 5-year range (0.93%–2.68%).

The free cash flow yield for IDEXX Laboratories, Inc. (IDXX) is 2.31% as of Tuesday, June 9, 2026. It is above its 12-month average by 24.27% (1.86%).

IDXX Free Cash Flow Yield Chart

IDXX Free Cash Flow Yield
2.31%+17.26% 1Y
Zoom

IDXX Average Free Cash Flow Yield Chart

IDXX Current vs Average Free Cash Flow Yield Chart

IDXX Free Cash Flow Yield Metrics

FREE CASH FLOW YIELD

2.31%

FREE CASH FLOW YIELD AVG TTM

1.86%

FREE CASH FLOW YIELD AVG 3Y

1.86%

FREE CASH FLOW YIELD AVG 5Y

1.65%

FREE CASH FLOW YIELD AVG 10Y

1.60%

FREE CASH FLOW YIELD AVG 15Y

1.98%

FREE CASH FLOW YIELD AVG 20Y

2.22%

CURRENT VS TTM AVG

+24.27%

CURRENT VS 3Y AVG

+24.23%

CURRENT VS 5Y AVG

+39.93%

CURRENT VS 10Y AVG

+44.45%

CURRENT VS 15Y AVG

+16.59%

CURRENT VS 20Y AVG

+3.92%

IDXX Competitors' Free Cash Flow Yield

NAMEMARKET CAPFREE CASH FLOW YIELDTTM3Y5Y
IDEXX Laboratories, Inc. (IDXX)2.31%1.86%1.86%1.65%
Humana Inc. (HUM)$43.60B2.90%5.42%8.60%7.29%
Agilent Technologies, Inc. (A)$38.26B3.26%3.06%3.54%3.21%
Zoetis Inc. (ZTS)$34.46B6.15%4.05%2.89%2.46%
Centene Corporation (CNC)$32.69B19.34%15.10%11.64%11.85%
IQVIA Holdings Inc. (IQV)$31.09B8.45%7.33%5.48%5.07%
DexCom, Inc. (DXCM)$30.17B4.64%3.31%2.07%1.40%
Biogen Inc. (BIIB)$29.39B8.88%9.21%6.93%6.70%
Regeneron Pharmaceuticals, Inc. (REGN)$63.48B6.26%5.46%4.49%5.45%
Veeva Systems Inc. (VEEV)$27.37B1.86%3.52%3.07%2.74%

Yield Comparison

FCF Yield

2.31%

Earnings Yield

2.34%

Dividend Yield

N/A

Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100

How FCF Yield is used:

  • Shows free cash flow after capital expenditures relative to market cap
  • Can be compared with earnings yield and dividend yield
  • Can be compared with the company's historical range
  • Can be compared with peers that report positive free cash flow

FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.

IDEXX Laboratories, Inc. Free Cash Flow Yield Formula & Definition

FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

IDEXX Laboratories, Inc. Free Cash Flow Yield FAQ

What is the free cash flow yield for IDEXX Laboratories, Inc. (IDXX)?
The free cash flow yield for IDXX stock is 2.31%.
Is IDEXX Laboratories, Inc.'s free cash flow yield high or low?
IDEXX Laboratories, Inc.'s free cash flow yield of 2.31% is 40% above its 5-year average of 1.65%, near the high end of its 5-year range (0.93%–2.68%).
What is the TTM average free cash flow yield for IDEXX Laboratories, Inc. (IDXX)?
The TTM average free cash flow yield for IDXX stock is 1.86%.
What is the 3Y average free cash flow yield for IDEXX Laboratories, Inc. (IDXX)?
The 3Y average free cash flow yield for IDXX stock is 1.86%.
What is the 5Y average free cash flow yield for IDEXX Laboratories, Inc. (IDXX)?
The 5Y average free cash flow yield for IDXX stock is 1.65%.
What is the 10Y average free cash flow yield for IDEXX Laboratories, Inc. (IDXX)?
The 10Y average free cash flow yield for IDXX stock is 1.60%.
What is the 15Y average free cash flow yield for IDEXX Laboratories, Inc. (IDXX)?
The 15Y average free cash flow yield for IDXX stock is 1.98%.
What is the 20Y average free cash flow yield for IDEXX Laboratories, Inc. (IDXX)?
The 20Y average free cash flow yield for IDXX stock is 2.22%.

IDEXX Laboratories, Inc. Free Cash Flow Yield History

DATEFREE CASH FLOW YIELD
2026-06-092.31%
2026-06-082.38%
2026-06-052.38%
2026-06-042.37%
2026-06-032.39%
2026-06-022.43%
2026-06-012.36%
2026-05-292.37%
2026-05-282.36%
2026-05-272.43%
2026-05-262.40%
2026-05-222.39%
2026-05-212.42%
2026-05-202.42%
2026-05-192.45%
2026-05-182.45%
2026-05-152.53%
2026-05-142.51%
2026-05-132.53%
2026-05-122.51%
2026-05-112.52%
2026-05-082.39%
2026-05-072.34%
2026-05-062.31%
2026-05-052.38%
2026-05-042.32%
2026-05-012.30%
2026-04-302.33%
2026-04-292.36%
2026-04-282.30%
2026-04-272.27%
2026-04-242.31%
2026-04-232.33%
2026-04-222.26%
2026-04-212.29%
2026-04-202.24%
2026-04-172.22%
2026-04-162.29%
2026-04-152.25%
2026-04-142.24%
2026-04-132.27%
2026-04-102.32%
2026-04-092.23%
2026-04-082.21%
2026-04-072.27%
2026-04-062.26%
2026-04-022.29%
2026-04-012.31%
2026-03-312.32%
2026-03-302.34%
2026-03-272.34%
2026-03-262.28%
2026-03-252.27%
2026-03-242.29%
2026-03-232.26%
2026-03-202.26%
2026-03-192.25%
2026-03-182.26%
2026-03-172.22%
2026-03-162.23%
2026-03-132.28%
2026-03-122.29%
2026-03-112.17%
2026-03-102.18%
2026-03-092.14%
2026-03-062.15%
2026-03-052.11%
2026-03-042.01%
2026-03-032.05%
2026-03-022.05%
2026-02-271.99%
2026-02-261.98%
2026-02-251.99%
2026-02-242.01%
2026-02-232.10%
2026-02-202.05%
2026-02-191.87%
2026-02-181.86%
2026-02-171.89%
2026-02-131.88%
2026-02-121.91%
2026-02-111.82%
2026-02-101.83%
2026-02-091.85%
2026-02-061.83%
2026-02-051.84%
2026-02-041.84%
2026-02-031.87%
2026-02-021.85%
2026-01-301.76%
2026-01-291.75%
2026-01-281.72%
2026-01-271.70%
2026-01-261.69%
2026-01-231.70%
2026-01-221.71%
2026-01-211.70%
2026-01-201.72%
2026-01-161.65%
2026-01-151.66%
2026-01-141.66%
2026-01-131.66%
2026-01-121.63%
2026-01-091.66%
2026-01-081.66%
2026-01-071.65%
2026-01-061.67%
2026-01-051.73%
2026-01-021.76%
2025-12-311.75%
2025-12-301.73%
2025-12-291.72%
2025-12-261.72%
2025-12-241.72%
2025-12-231.73%
2025-12-221.68%
2025-12-191.69%
2025-12-181.70%
2025-12-171.70%
2025-12-161.71%
2025-12-151.69%
2025-12-121.68%
2025-12-111.67%
2025-12-101.68%
2025-12-091.69%
2025-12-081.67%
2025-12-051.66%
2025-12-041.65%
2025-12-031.63%
2025-12-021.61%
2025-12-011.62%
2025-11-281.57%
2025-11-261.56%
2025-11-251.54%
2025-11-241.57%
2025-11-211.63%
2025-11-201.71%
2025-11-191.70%
2025-11-181.76%
2025-11-171.77%
2025-11-141.71%
2025-11-131.68%
2025-11-121.66%
2025-11-111.66%
2025-11-101.67%
2025-11-071.67%
2025-11-061.66%
2025-11-051.64%
2025-11-041.64%
2025-11-031.64%
2025-10-311.52%
2025-10-301.52%
2025-10-291.52%
2025-10-281.51%
2025-10-271.48%
2025-10-241.49%
2025-10-231.50%
2025-10-221.51%
2025-10-211.50%
2025-10-201.49%
2025-10-171.50%
2025-10-161.50%
2025-10-151.50%
2025-10-141.50%
2025-10-131.51%
2025-10-101.55%
2025-10-091.52%
2025-10-081.52%
2025-10-071.52%
2025-10-061.52%
2025-10-031.51%
2025-10-021.51%
2025-10-011.54%
2025-09-301.50%
2025-09-291.52%
2025-09-261.51%
2025-09-251.55%
2025-09-241.52%
2025-09-231.47%
2025-09-221.48%
2025-09-191.46%
2025-09-181.46%
2025-09-171.49%
2025-09-161.48%
2025-09-151.48%
2025-09-121.49%
2025-09-111.48%
2025-09-101.50%
2025-09-091.46%
2025-09-081.46%
2025-09-051.49%
2025-09-041.49%
2025-09-031.51%
2025-09-021.49%
2025-08-291.48%
2025-08-281.48%
2025-08-271.49%
2025-08-261.49%
2025-08-251.49%
2025-08-221.48%
2025-08-211.51%
2025-08-201.49%
2025-08-191.50%
2025-08-181.50%
2025-08-151.47%
2025-08-141.46%
2025-08-131.44%
2025-08-121.47%
2025-08-111.47%
2025-08-081.45%
2025-08-071.47%
2025-08-061.53%
2025-08-051.49%
2025-08-041.40%
2025-08-011.91%
2025-07-311.91%
2025-07-301.79%
2025-07-291.78%
2025-07-281.81%
2025-07-251.81%
2025-07-241.86%
2025-07-231.89%
2025-07-221.92%
2025-07-211.96%
2025-07-181.99%
2025-07-171.97%
2025-07-161.96%
2025-07-151.94%
2025-07-141.92%
2025-07-111.92%
2025-07-101.89%
2025-07-091.89%
2025-07-081.90%
2025-07-071.87%
2025-07-031.87%
2025-07-021.88%
2025-07-011.88%
2025-06-301.91%
2025-06-271.92%
2025-06-261.94%
2025-06-251.93%
2025-06-241.93%
2025-06-231.95%
2025-06-201.95%
2025-06-181.97%
2025-06-171.96%
2025-06-161.93%
2025-06-131.96%
2025-06-121.94%
2025-06-111.95%
2025-06-101.94%
2025-06-091.97%
2025-06-061.95%
2025-06-051.96%
2025-06-041.95%
2025-06-031.94%
2025-06-021.99%
2025-05-301.99%
2025-05-291.98%
2025-05-281.99%

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

Westbrook, ME
11,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jonathan J. Mazelsky